Clinical Characteristics and Treatment Outcomes of 65 Patients With BRAF-Mutated Non-small Cell Lung Cancer

BRAF mutation is an oncogenic driver gene in non-small cell lung cancer (NSCLC) with low frequency. The data of patients with NSCLC harboring BRAF mutations is rare. We conducted a retrospective multicenter study in Chinese patients with NSCLC harboring BRAF mutations between Jan 2017 and Jul 2019....

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yuxin Mu, Ke Yang, Xuezhi Hao, Yan Wang, Lin Wang, Yutao Liu, Lin Lin, Junling Li, Puyuan Xing
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2020-04-01
Colecção:	Frontiers in Oncology
Assuntos:	BRAF mutation chemotherapy immunotherapy non-small cell lung cancer targeted therapy
Acesso em linha:	https://www.frontiersin.org/article/10.3389/fonc.2020.00603/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!